| 摘要 |
A composition for treating a bone defect comprises an osteogenic protein as a first biologically active agent, a calcium phosphate material as a carrier and an effective amount of an effervescent agent. Preferably the protein is selected from the BMP protein family and the effervescent agent is a gas selected from carbon dioxide, air, nitrogen, helium, oxygen, and argon, or sodium bicarbonate.
|
